Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [clinicaltrials:NCT00002790]
Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [clinicaltrials:NCT00002790]
Bio2RDF identifier
NCT00002790
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00002790
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Bone marrow ...... ing a bone marrow transplant.
brief title [clinicaltrials_vocabulary:brief-title]
Prevention of Graft-Versus-Hos ...... iving a Bone Marrow Transplant
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Estimate ...... be accrued over 1-2.5 years.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
adult acute lymphoblastic leukemia
adult acute myeloid leukemia
childhood acute lymphoblastic leukemia
childhood acute myeloid leukemia/other myeloid malignancies
childhood myelodysplastic syndromes
chronic lymphocytic leukemia
chronic myelogenous leukemia
graft versus host disease
myelodysplastic syndromes
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-03-04T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00002790
official title [clinicaltrials_vocabulary:official-title]
A PHASE I/II STUDY OF RAPAMYCI ...... AFT-VERSUS-HOST DISEASE (GVHD)
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
FHCRC-1096.00
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1996-03-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2015-03-01T00:00:00Z
identifier
clinicaltrials:NCT00002790
title
Prevention of Graft-Versus-Hos ...... iving a Bone Marrow Transplant
@en
type
label
Prevention of Graft-Versus-Hos ...... t [clinicaltrials:NCT00002790]
@en